Theriva Biologics, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Theriva Biologics, Inc. annual/quarterly Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2023.
  • Theriva Biologics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2023 was -$3.3M, a 26.4% increase year-over-year.
  • Theriva Biologics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$18.3M, a 6.79% increase from 2022.
  • Theriva Biologics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$19.7M, a 38% decline from 2021.
  • Theriva Biologics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$14.3M, a 42.1% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$3.3M +$1.19M +26.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q4 2022 -$19.7M -$6.45M -$1.18M -22.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-25
Q3 2022 -$18.5M -$4.49M -$1.22M -37.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$17.3M -$4.48M -$1.28M -40.1% Apr 1, 2022 Jun 30, 2022 10-K 2023-03-30
Q1 2022 -$16M -$4.27M -$1.74M -68.5% Jan 1, 2022 Mar 31, 2022 10-K 2023-03-30
Q4 2021 -$14.3M -$5.26M -$3.15M -150% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$11.1M -$3.27M -$1.17M -55.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$9.94M -$3.2M -$328K -11.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-10
Q1 2021 -$9.62M -$2.54M +$428K +14.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-10
Q4 2020 -$10M -$2.11M +$1.03M +32.8% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-16
Q3 2020 -$11.1M -$2.1M +$3.02M +58.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 -$14.1M -$2.87M +$664K +18.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-03
Q1 2020 -$14.8M -$2.96M +$548K +15.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-03
Q4 2019 -$15.3M -$3.14M +$53K +1.66% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-04
Q3 2019 -$15.4M -$5.12M -$1.44M -39.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$13.9M -$3.53M +$667K +15.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-10
Q1 2019 -$14.6M -$3.51M -$1.2M -51.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-10
Q4 2018 -$13.4M -$3.19M -$6.01M -214% Oct 1, 2018 Dec 31, 2018 10-K 2019-02-27
Q3 2018 -$7.38M -$3.68M +$7.25M +66.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-04
Q2 2018 -$14.6M -$4.2M +$117K +2.71% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-04
Q1 2018 -$14.7M -$2.32M +$742K +24.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-04
Q4 2017 -$15.5M $2.81M +$5.28M Oct 1, 2017 Dec 31, 2017 10-K 2019-02-27
Q3 2017 -$20.8M -$10.9M -$2.44M -28.8% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-27
Q2 2017 -$18.3M -$4.32M +$1.45M +25.1% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-27
Q1 2017 -$19.8M -$3.06M +$8.02M +72.4% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-27
Q4 2016 -$27.8M -$2.47M +$8.82M +78.1% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-22
Q3 2016 -$36.6M -$8.49M -$982K -13.1% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-22
Q2 2016 -$35.6M -$5.76M +$7.86M +57.7% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-22
Q1 2016 -$43.5M -$11.1M +$1.28M +10.4% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-22
Q4 2015 -$44.8M -$11.3M -$4.82M -74.3% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-02
Q3 2015 -$40M -$7.51M -$2.6M -52.9% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-02
Q2 2015 -$37.4M -$13.6M -$9.07M -199% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-02
Q1 2015 -$28.3M -$12.4M -$8.52M -222% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-02
Q4 2014 -$19.8M -$6.48M -$2.26M -53.4% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-10
Q3 2014 -$17.5M -$4.91M -$1.54M -45.8% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-10
Q2 2014 -$16M -$4.56M -$2.06M -82.5% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-10
Q1 2014 -$13.9M -$3.84M -$1.61M -72.3% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-10
Q4 2013 -$12.3M -$4.23M +$7.84M +65% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-16
Q3 2013 -$20.2M -$3.37M -$1.44M -74.5% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-16
Q2 2013 -$18.7M -$2.5M -$625K -33.4% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-16
Q1 2013 -$18.1M -$2.23M -$1.03M -85.7% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-16
Q4 2012 -$17.1M -$12.1M -$8.88M -279% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-16
Q3 2012 -$8.19M -$1.93M -$832K -75.8% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$7.36M -$1.87M -$192K -11.4% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$7.16M -$1.2M +$986K +45.1% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 -$8.15M -$3.19M Oct 1, 2011 Dec 31, 2011 10-K 2013-04-16
Q3 2011 -$1.1M -$365K -49.8% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 -$1.68M -$2.66M -271% Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-09-11
Q1 2011 -$2.19M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q3 2010 -$733K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 $980K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.